Michael Secora

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RXRX

Current role

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Recursion Pharmaceuticals, Inc. (RXRX)	Former Chief Financial Officer	$475,000	—	$1,757,577	$2,233,116	—	$577,813	$5,043,506
2023	Recursion Pharmaceuticals, Inc. (RXRX)	Former Chief Financial Officer	$435,583	—	$1,730,759	$2,153,839	$174,369	$19,830	$4,514,381
2022	Recursion Pharmaceuticals, Inc. (RXRX)	Former Chief Financial Officer	$348,250	—	$721,107	$845,127	$129,834	$46,104	$2,090,422
2021	Recursion Pharmaceuticals, Inc. (RXRX)	Chief Financial Officer	$307,708	$63,460	—	—	$126,000	$13,174	$510,342
2020	Recursion Pharmaceuticals, Inc. (RXRX)	Chief Financial Officer	$170,833	$63,000	—	$3,431,798	$15,357	$37,500	$3,718,488

No earnings-call appearances or filed executive changes recorded yet.